glp-3rt retatrutide GLP-3 RT Peptide – US Delivery GLP-3 RT (Retatrutide)

A clinical trial found that in patients with MCI, a 32-week trial of slow-release exenatide had no beneficial effect on cognitive performance (Dei Cas et al., 2024)

Levothyroxine injections bypass the intestinal tract entirely, which solves the absorption problems that make oral levothyroxine ineffective for many thyroid patients

The SELECT trial tested semaglutide 2.4 mg in over 17,000 people with cardiovascular disease and obesity over an average of 3.3 years

Consumption Everyone from Morgan Stanley, to Reuters, to Jeffries, to the twittersphere has been commenting on the potential changes to purchasing behavior for patients on GLP1s